Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Sinobioway Bioeconomy Group is a core industrial entity within the Sinobioway Group, focused on establishing a comprehensive bio-economy ecosystem in China. Based in Hefei, the company operates large-scale bio-industrial parks that integrate research, development, and manufacturing across biopharmaceuticals, agriculture, and environmental protection. Its healthcare portfolio is primarily managed through subsidiaries and includes significant assets in vaccines, monoclonal antibodies, and recombinant proteins. The group is known for its "Bio-economy" development model, which seeks to create closed-loop industrial chains supported by extensive infrastructure and government partnerships. Currently, the company supports a pipeline of biosimilars and innovative biologics targeting oncology, neurology, and autoimmune disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Sinobioway Bioeconomy Group.